Xelia Bacitracin vials 50.000 units

Xelia Bacitracin Vials 50.000 Units is comprised of a polypeptide complex and bacitracin A is the major component in this complex active against a variety of Gram-positive bacteria and a few Gram-negative bacteria, however only staphylococcal infections qualify for the systemic therapy.

Certifications & Compliance: FDA Compliant, GMP, United States Pharmacopeia (USP)

Dosage Form: Injectables

Similar Products

  • TypeDocument Name
View All Documents

Knowde Enhanced TDS

Identification & Functionality

Chemical Family
Pharma & Nutraceuticals Functions

Features & Benefits

Features

Dosage form : Lyophilized vials
Strength   : 50 000 units/vial
Manufacturing site: CMO for Xellia Pharmaceuticals ApS
Release site : CMO for Xellia Pharmaceuticals ApS
Site registered  : EU GMP issued by Medicines and Healthcare products Regulatory Agency, US FDA, Other health authorities

Applications & Uses

Dosage Form
Applications

Administered systemically as intramuscular injections.

Properties

Physical Form

Regulatory & Compliance

Compliance

USP

Regulatory documentation

US dossier

Packaging & Availability

Packaging Type
Batch size

35 000 vials
17 000 vials

Packaging sizes

1 vial/pack
10 vials/pack

Storage & Handling

Shelf-life

24 months

Storage conditions

Between 2-8°C (36-46°F)